(Q54590637)

English

The search for CNI-free immunosuppression: no free lunch.

scientific article

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21564526

editorial

0 references

title

The search for CNI-free immunosuppression: no free lunch. (English)

1 reference

stated in

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21564526

1 reference

H-U Meier-Kriesche

1

1 reference

stated in

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21564526

B Kaplan

series ordinal

2

1 reference

stated in

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21564526

language of work or name

English

0 references

publication date

12 May 2011

1 reference

stated in

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21564526

published in

American Journal of Transplantation

1 reference

stated in

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21564526

volume

11

1 reference

stated in

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21564526

issue

7

1 reference

stated in

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21564526

page(s)

1355-1356

1 reference

stated in

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21564526

cites work

Sotrastaurin, a novel small molecule inhibiting protein-kinase C: randomized phase II study in renal transplant recipients.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2011.03541.X

retrieved

21 January 2018

Calcineurin-inhibitor-free immunosuppression based on the JAK inhibitor CP-690,550: a pilot study in de novo kidney allograft recipients

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2011.03541.X

retrieved

21 January 2018

A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study).

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2011.03541.X

retrieved

21 January 2018

Sotrastaurin, a novel small molecule inhibiting protein kinase C: first clinical results in renal-transplant recipients.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2011.03541.X

retrieved

21 January 2018

Identifiers

DOI

10.1111/J.1600-6143.2011.03541.X

1 reference

stated in

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21564526

PubMed ID

21564526

1 reference

stated in

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21564526

ResearchGate publication ID

51119329

0 references

(Q54590637)

The search for CNI-free immunosuppression: no free lunch.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)